Sero As - The Independent Control Sera Specialist company information, Employees & Contact Information

WATCH: Trump announces deal with EMD Serono to lower fertility drug prices PBS

EMD Serono partners US government to widen IVF access Pharmaceutical Technology

Merck KGaA's EMD Serono strikes MFN deal in Trump's fertility treatment pricing push Fierce Pharma

EMD Serono Announces Unprecedented Agreement with U.S. Government to Expand Access to IVF Therapies Business Wire

Trump announces plan to lower cost of IVF drugs Axios

In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program BioSpace

White House makes new ‘most favored nation’ deal, shares updates on FDA vouchers, GLP-1 negotiations Endpoints News

EMD Serono’s Agreement with US Government Pharmaceutical Executive

Trump Announces Lower-Cost Fertility Drug Deal With EMD Serono deltanews.tv

EMD Serono IVF Candidate Among First US FDA Priority Voucher Recipients As Part Of MFN Deal Citeline News & Insights

Trump Announces Deal with Pharma Giant EMD Serono: What it Means for IVF Treatment in America Times Now

EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026 Benzinga

ASCO 2025: EMD Serono to Highlight Data from Studies Across more than 12 Tumor Types Onco'Zine

EMD Serono Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025 Yahoo Finance

Merck Serono Sets Up Biotech Incubator in Israel CHEManager

Bank to consolidate HQ into former EMD Serono office The Business Journals

EMD Serono to Present New Data Highlighting Durable Effects of MAVENCLAD Business Wire

EMD Serono Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025 BioSpace

Merck KGaA's EMD Serono taps Selma Blair to join long-running campaign for MS drug Mavenclad Fierce Pharma

EMD Serono Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active Lupus Rash Business Wire

Selma Blair collabs with EMD Serono for DTC campaign about relapsing MS Medical Marketing and Media

Merck Serono and Mersana Collaborate on Antibody Drug Conjugates CHEManager

EMD Serono and SiS launch corporate accelerator programme for women's health innovators FemTech World

EMD Serono’s new president is on the hunt for deals in Boston The Business Journals

BRIEF-EMD Serono Announces Agreement With U.S. Government To Expand Access To IVF Therapies Devdiscourse

Fernández Alcalde takes the reins at EMD Serono, one of Boston’s newest biotechs The Boston Globe

EMD Serono Appoints Miguel Fernández Alcalde to Lead North American Healthcare Business Business Wire

Merck KGaA names new president for EMD Serono The Pharma Letter

Ribbon-cutting ceremony in EMD Serono's headquarters in the Seaport district - Merck Healthcare Oncodaily

Merck KGaA's pharma unit joins the healthcare migration to Boston's Seaport innovation hub Fierce Pharma

EMD Serono gives $100K to support MS nursing scholarship fund Multiple Sclerosis News Today

Drugmaker EMD Serono leaves longtime suburban home for Seaport HQ The Business Journals

EMD Serono, Inc. Massachusetts Biotechnology Council

How EMD Serono plans to hit its lofty goals in R&D Pharma Voice

Aspiring to Create, Improve and Prolong Life at EMD Serono Technology Magazine

Merck Serono’s Pharmaceutical Manufacturing Facility, Nantong, China Pharmaceutical Technology

14th Annual EMD Serono Specialty Digest™ Educates Health Plans on Latest Trends in Unmet Payer Needs and Patient-Centric Services PR Newswire

Sonnet bags ex-Serono neuropathy drug via Relief Therapeutics deal Fierce Biotech

Best Office/Retail/Mixed-Use: EMD Serono Horizon Building Engineering News-Record

Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America PR Newswire

Chutes & Ladders—Merck KGaA's US wing names Miguel Fernández Alcalde new COO Fierce Biotech

40 Under 40: Ariane Dumas, EMD Serono Medical Marketing and Media

Swiss hope for phoenix from Merck Serono's ashes Nature

Family history drives EMD Serono’s Lori Lebson The Boston Globe

EMD Serono, Canada Sign Agreement for Public Health Plan Funding of Mavenclad for RRMS Multiple Sclerosis News Today

EMD Serono Launches MS-LINK™, a Community to Advance MS Science and Improve Patient Lives PR Newswire

EMD Serono targeted therapy gets speedy FDA approval for lung cancer MedCity News

Merck Serono Biopharmaceutical R&D Facility Expansion, Darmstadt Pharmaceutical Technology

EMD Serono selects Erland, PM Group, and BR+A Consulting Engineers for 15,000 s/f renovation NEREJ

Wyss Institute to rise in Merck Serono shell Nature

EMD Serono Announces Plans for New U.S. Healthcare Headquarters in Boston’s Seaport District Business Wire

EMD Serono Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity Business Wire

EMD Serono wins FDA nod for redesigned pen injector Drug Delivery Business

EMD Serono Receives FDA Approval for New GONAL-f® RFF Redi-ject® Pen PR Newswire

Merck KGaA’s U.S. unit launches first-ever TV ad with MS drug Mavenclad in the spotlight Fierce Pharma

For MS, Mavenclad Stands Out From Other Therapies, EMD Serono Says Multiple Sclerosis News Today

EMD Serono’s Egrifta effective against drug-induced fatty liver disease in trial BioPharma Dive

CMSC16 - Medical Affairs VP at EMD Serono Discusses MS Drug Rebif, MS LifeLines Support in Exclusive Interview Multiple Sclerosis News Today

EMD Serono introduces new Fertility Technologies unit Fierce Biotech

EMD Serono to move HQ to Seaport from the suburbs The Business Journals

Merck Serono Funds Scientific Innovation drugdiscoverytrends.com

Rockland-based EMD Serono on the front lines of improving lives The Patriot Ledger

FDA Withdraws NDA for Fertility Drug After EMD Serono Fails to Run Postmarket Trial Regulatory Affairs Professionals Society | RAPS

EMD Serono headquarters plans to join biopharma cluster in Boston’s Seaport The Boston Globe

Paris Panayiotopoulos is the new president and managing director of EMD Serono Boston.com

EMD Serono launches counterfeit-fighting app Anti-counterfeiting news

EMD Serono Supports Military Community By Providing Access to Fertility Care Through Focused Patient Assistance Programs MultiVu

Merck Serono completes move to Germany PMLiVE

Merck Rebranding Drops Serono and Millipore Names CHEManager

Merck Serono pays $44 million to settle kickback charge Cleveland.com

EMD Serono Appoints Manuel Zafra as New Managing Director for Canada PR Newswire Canada

Serono to Pay $704 Million for Deceptive Aids Drug Sales Chemical & Engineering News

New CEO for Merck Serono PMLiVE

EMD Serono launches the easypod The Patriot Ledger

Serono LNG Project, Central Sulawesi, Indonesia Offshore Technology

Merck Serono – The right medicine for the job Executive Magazine

Serono sells majority share to Merck SWI swissinfo.ch

Serono ordered to settle fraud case SWI swissinfo.ch

Geneva hit by Merck Serono job cuts SWI swissinfo.ch